Search results for "Right ventricular"

showing 4 items of 44 documents

Prognostic role of tapse to pasp ratio in patients undergoing mitraclip procedure

2021

Producción Científica

medicine.medical_specialtyTransthoracic echocardiographyCorazón - Cirugíamedicine.medical_treatmentCardiology3205.01 Cardiologíalcsh:MedicineHeart valves - Diseases - diagnostic imaging030204 cardiovascular system & hematologyRight ventricular to pulmonary arterial couplingArticlePulmonary hypertension03 medical and health sciencesmitral valve repairtransthoracic echocardiography0302 clinical medicineInternal medicinepulmonary hypertensionmedicineMitraClipCorazón - Enfermedades030212 general & internal medicineMitral valve repairMitral regurgitationMitral valve - Diseases - ImagingProportional hazards modelbusiness.industryMitraClipmitral valve regurgitationlcsh:RGeneral MedicineCardiac surgerymedicine.disease3207.04 Patología CardiovascularPulmonary hypertensionHipertensión pulmonarBlood pressureEchocardiographyHeart failureCardiologyright ventricular to pulmonary arterial couplingHeart - DiseasesMitral valve regurgitationbusinessMitral valve repairMitral valve regurgitation
researchProduct

Defining right ventricular dysfunction by the use of echocardiography in normotensive patients with pulmonary embolism

2020

Although the prognostic value of various echocardiographic parameters of right ventricular dysfunction (RVD) was reported in normotensive patients with acute pulmonary embolism (PE), there is no generally accepted definition of RVD.The aim of the study was to compare echocardiographic parameters for the prediction of an adverse 30‑day outcome and create an optimal definition of RVD.                                     Patients and methods: Echocardiographic parameters including the right ventricular to left ventricular diameter ratio (RV to LV ratio) and tricuspid annular plane systolic excursion (TAPSE) to predict PE‑related mortality, hemodynamic collapse, or rescue thrombolysis within th…

medicine.medical_specialtyVentricular Dysfunction Rightmedicine.medical_treatmentHemodynamicsBlood Pressure030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineHumansMedicineProspective Studies030212 general & internal medicineReceiver operating characteristicbusiness.industryArea under the curveThrombolysismedicine.diseaseRight ventricular dysfunction3. Good healthPulmonary embolismBlood pressureIncreased riskEchocardiographyCardiologyPulmonary EmbolismbusinessPolish Archives of Internal Medicine
researchProduct

Treatment decision making in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: State of the art

2014

No abstract available

medicine.medical_specialtymedicine.medical_treatmentDecision MakingCardiomyopathySudden deathImplantable cardioverter-defibrillatorAntiarrhythmic drugs; Cardiac transplantation; Implantable cardioverter-defibrillator; Management; Radiofrequency catheter ablation; Sudden death; Arrhythmogenic Right Ventricular Dysplasia; Decision Making; HumansAntiarrhythmic drugs; Cardiac transplantation; Implantable cardioverter-defibrillator; Management; Radiofrequency catheter ablation; Sudden deathInternal medicinemedicineHumansIn patientIntensive care medicineArrhythmogenic Right Ventricular DysplasiaRadiofrequency catheter ablationbusiness.industrySudden deathImplantable cardioverter-defibrillatormedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareArrhythmogenic right ventricular dysplasiaAntiarrhythmic drugsManagementAntiarrhythmic drugRadiofrequency catheter ablationCardiologyCardiac transplantationTreatment decision makingCardiology and Cardiovascular Medicinebusiness
researchProduct

Pulmonary Embolism: Contemporary Medical Management and Future Perspectives

2018

Pulmonary embolism (PE) contributes substantially to the global disease burden. A key determinant of early adverse outcomes is the presence (and severity) of right ventricular dysfunction. Consequently, risk-adapted management strategies continue to evolve, tailoring acute treatment to the patients' clinical presentation, hemodynamic status, imaging and biochemical markers, and comorbidity. For subjects with hemodynamic instability or 'high-risk' PE, immediate systemic reperfusion treatment with intravenous thrombolysis is indicated; emerging approaches such as catheter-directed pharmacomechanical reperfusion might help to minimize the bleeding risk. Currently, direct, non-vitamin K-depende…

medicine.medical_specialtythrombolysispulmonary embolismmedicine.medical_treatmentvenous thromboembolismHemodynamicsReview Articlerisk stratification030204 cardiovascular system & hematologyVitamin kdirect oral anticoagulants03 medical and health sciences0302 clinical medicinemedicine030212 general & internal medicineIntensive care medicineDisease burdenbusiness.industryGeneral MedicineThrombolysismedicine.diseaseComorbidityRight ventricular dysfunctionReview articlePulmonary embolismright ventricular dysfunctionbusinessAnnals of Vascular Diseases
researchProduct